FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity
Allergan plc (NYSE: AGN), a leading global pharmaceutical company today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's resubmission of its Supplemental Biologics ...
Expert Rev Neurother. 2009;9(12):1713-1725. The first patients with squint were successfully treated in 1977 [17] and since then botulinum toxin type A delivered by local injection has been used in ...
Ipsen (GB:0MH6) announced an update on their ongoing clinical study. Study Overview: Ipsen recently completed a study titled A Multicentre, Interventional, Post-marketing, Randomised, Double-blind, ...
NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA (BOTOX®) ...
Botox can be used for both medical purposes, such as helping to prevent migraine, and for cosmetic purposes, such as helping to reduce wrinkles. It is more likely to be covered when used for medical ...
NEW YORK (Reuters Health) - As a treatment for muscle stiffness in children with cerebral palsy, shots of botulinum toxin A, best known by the brand name Botox, are safe and produce measurable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback